Prestige Consumer Healthcare (PBH) Receivables - Net (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Receivables - Net of $190.5 million for Q4 2025, up 13.86% year-over-year from $167.3 million in Q4 2024, and down 4.29% quarter-over-quarter from $199.0 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Receivables - Net (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Receivables - Net history runs 15 years deep, the most recent figure standing at $190.5 million for Q4 2025.
- In Q4 2025, Receivables - Net rose 13.86% year-over-year to $190.5 million; the TTM figure through Dec 2025 stood at $190.5 million (up 13.86% YoY), while the FY2025 annual figure was $194.3 million, up 9.91% from the prior year.
- Receivables - Net for Q4 2025 stood at $190.5 million, down from $199.0 million in the prior quarter.
- The five-year high for Receivables - Net was $199.0 million in Q3 2025, with the low at $114.7 million in Q1 2021.
- The 5-year median for Receivables - Net is $161.3 million (2022), against an average of $161.1 million.
- The sharpest annual moves came in 2021 and 2022: Receivables - Net plunged 32.83% in 2021, then surged 38.7% in 2022.
- Prestige Consumer Healthcare's Receivables - Net stood at $134.3 million in 2021, then climbed by 17.0% to $157.1 million in 2022, then climbed by 10.95% to $174.3 million in 2023, then dropped by 4.02% to $167.3 million in 2024, then gained by 13.86% to $190.5 million in 2025.
- Business Quant data shows PBH's Receivables - Net at $190.5 million in Q4 2025, $199.0 million in Q3 2025, and $168.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 191.92 Mn |
| Mar 31, 2026 | 191.92 Mn |
| Dec 31, 2025 | 190.46 Mn |
| Dec 31, 2025 | 190.46 Mn |
| Sep 30, 2025 | 199.00 Mn |
| Sep 30, 2025 | 199.00 Mn |
| Jun 30, 2025 | 168.41 Mn |
| Jun 30, 2025 | 168.41 Mn |
| Mar 31, 2025 | 194.29 Mn |
| Mar 31, 2025 | 194.29 Mn |
| Dec 31, 2024 | 167.27 Mn |
| Dec 31, 2024 | 167.27 Mn |
| Sep 30, 2024 | 163.55 Mn |
| Sep 30, 2024 | 163.55 Mn |
| Jun 30, 2024 | 171.70 Mn |
| Jun 30, 2024 | 171.70 Mn |
| Mar 31, 2024 | 176.78 Mn |
| Mar 31, 2024 | 176.78 Mn |
| Dec 31, 2023 | 174.29 Mn |
| Dec 31, 2023 | 174.29 Mn |